Relationships between personality disorders and anthropometry, hormones and metabolism in women.
This study sought to examine the potential influence of personality disorders (PD) on anthropometry, hormones and metabolism in women. In a population sample of women born in 1956 (no.=270), estimates of PD:s by Structured Clinical Interview for DSM-III-R, Axis II, were correlated with anthropometric, endocrine, and metabolic factors. The PD:s were grouped into three thematic clusters: cluster A (characterized by oddness or eccentricity), cluster B (characterized by self-centeredness, emotionality, and erratic behavior) and cluster C (characterized by anxiety and fear). Subjects with cluster A PD:s had significantly increased body mass index (BMI, kg/m2) and abdominal sagittal diameter (cm) as well as lower salivary cortisol after dexamethasone (DEX) compared to controls. Subjects with cluster B also had a significantly higher abdominal sagittal diameter and significantly lower salivary cortisol levels after DEX than controls. In addition, subjects with cluster B PD:s had decreased levels of ACTH, and significantly higher concentrations of lactate and triglycerides, while high-density lipoprotein (HDL) cholesterol was significantly lower compared to controls. A significantly higher waist/hip ratio was seen among subjects with cluster C PD:s. In addition, these subjects had higher levels of insulin, glucose, lactate, triglycerides, total cholesterol and low-density lipoprotein (LDL) cholesterol than controls. Moreover, IGF-I and HDL cholesterol were significantly decreased in the former group. These results suggest that PD:s are involved in the development of obesity and abdominal fat accumulation in women, with different endocrine and metabolic profiles depending on the type of PD.
Rosmond
R
R
Department of Heart and Lung Diseases, Göteborg University, Sahlgrenska University Hospital, Sweden.
Baghei
F
F
Holm
G
G
Björntorp
P
P
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000342:Affective Symptoms / Q000503:physiopathology; D000886:Anthropometry; D001007:Anxiety / Q000503:physiopathology; D001786:Blood Glucose / Q000032:analysis; D001824:Body Constitution; D015992:Body Mass Index; D008076:Cholesterol, HDL / Q000097:blood; D003907:Dexamethasone; D005239:Fear; D005260:Female; D005938:Glucocorticoids; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis; D007328:Insulin / Q000097:blood; D019344:Lactic Acid / Q000097:blood; D009765:Obesity / Q000209:etiology; D010554:Personality Disorders / Q000378:metabolism / Q000503:physiopathology*; D012463:Saliva / Q000737:chemistry; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008076:Cholesterol, HDL; D005938:Glucocorticoids; D006728:Hormones; D007328:Insulin; D014280:Triglycerides; D019344:Lactic Acid; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone